Kniha Biotechnology Valuation - An Introductory Guide Karl Keegan

Biotechnology Valuation - An Introductory Guide

Autor: Karl Keegan
Jazyk: Angličtina
Väzba: Pevná
Vydavateľ: John Wiley & Sons Inc
Dostupnosť: Skladom u dodávateľa
Odosielame za 10-18 dní
72.12
The first book to provide a simple and practical means of valuing biotech companies The book begins...

Informácie o knihe

Autor
Jazyk
Angličtina
Väzba
Kniha - Pevná
Vydalo
2008
Stránok
218
EAN
9780470511787
ISBN
0470511788
Enbook ID
04884086
Hmotnosť
548
Rozmery
174 x 258 x 22

Kompletný popis

The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation "Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start." -- Chris Blackwell , Chief Executive, Vectura Group plc "A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians." -- Steve Winokur , Managing Director, CanaccordAdams "A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value." -- Dr L.M. Allan , Director, Bioscience Enterprise Programme, University of Cambridge "A fabulous approach to a difficult topic." -- Deirdre Y. Gillespie , MD, President & CEO, La Jolla Pharmaceutical Company

Mohlo by vás zaujímať

CYPRESS BEACH

WILLIAM HEN BABCOCK
29.10

Persona 5, Vol. 4

Hisato Murasaki
9.40

Kahlil Earns His First Dollar

Mesenti Mykynte Mwari
9.50

The Adventures of Telemachus

Franc¸ois de S. de L. M. Fe´nelon
23.41

Healing Heart Poetry

Anthony Lee Fox
6.56

Echo Man

Sam Holland
10.48

Venin Abyss

Sheri Shields
19.69
11.36
8.71

90 Amazing Mandalas

Mathias G. Oxford
9.69
37.03

Biotechnology

Joel O. Almosara
24.78

Identity

Kenneth Soddy
98.29

Zákazníci, ktorí si kúpili túto knihu, kúpili tiež

48.99
18.61

Le Coeur de l'Univers

Meis Sophie Meis
14.00

Rumi et Shams

William Chittick
28.02
21.94

Poveri a noi

Elvio Carrieri
17.83
13.12

BALEINES ET DAUPHINS

Christiane Gunzi
10.77

EL FINAL DE LA MÀGIA

PEDRO MAÑAS ROMERO
10.67

One Piece 76

Eiichiro Oda
12.04
44.29

Vodka-Cola

Irina Denejkina
8.91
51.73